84 related articles for article (PubMed ID: 18431484)
1. Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering.
Schlaepfer E; Speck RF
PLoS One; 2008 Apr; 3(4):e1999. PubMed ID: 18431484
[TBL] [Abstract][Full Text] [Related]
2. Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapy.
Veneziani I; Alicata C; Moretta L; Maggi E
Immunol Lett; 2023 Sep; 261():13-16. PubMed ID: 37451320
[TBL] [Abstract][Full Text] [Related]
3. Jigsaw falling into place: A review and perspective of lymphoid tissue CD8+ T cells and control of HIV.
Nguyen S; Sada-Japp A; Petrovas C; Betts MR
Mol Immunol; 2020 Aug; 124():42-50. PubMed ID: 32526556
[TBL] [Abstract][Full Text] [Related]
4. Syntheses of fluorescent imidazoquinoline conjugates as probes of Toll-like receptor 7.
Shukla NM; Mutz CA; Ukani R; Warshakoon HJ; Moore DS; David SA
Bioorg Med Chem Lett; 2010 Nov; 20(22):6384-6. PubMed ID: 20933417
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Optimization of 1-Substituted Imidazo[4,5-
DeYoung EG; Howe JM; Fang S; Reddy MM; Handel JP; Gillen Miller JT; Wheeler DR; Tumey LN
ACS Med Chem Lett; 2023 Oct; 14(10):1358-1368. PubMed ID: 37849530
[TBL] [Abstract][Full Text] [Related]
6. Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko RR; Mailliard RB
J Leukoc Biol; 2023 Feb; 113(2):109-138. PubMed ID: 36822173
[TBL] [Abstract][Full Text] [Related]
7. Novel TLR7/8 agonists promote activation of HIV-1 latent reservoirs and human T and NK cells.
Li Y; Wang Z; Hou Y; Liu X; Hong J; Shi X; Huang X; Zhang T; Liao X; Zhang L
Front Microbiol; 2023; 14():1033448. PubMed ID: 36778871
[TBL] [Abstract][Full Text] [Related]
8. Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours.
Ge Y; Sun F; Zhao B; Kong F; Li Z; Kong X
Front Oncol; 2022; 12():1103446. PubMed ID: 36776356
[TBL] [Abstract][Full Text] [Related]
9. Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans.
Ayithan N; Ghosh A; Dwivedi A; Wallin JJ; Tan SK; Chen D; Kottilil S; Poonia B
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960669
[TBL] [Abstract][Full Text] [Related]
10. NK-B cell cross talk induces CXCR5 expression on natural killer cells.
Rascle P; Jacquelin B; Petitdemange C; Contreras V; Planchais C; Lazzerini M; Dereuddre-Bosquet N; Le Grand R; Mouquet H; Huot N; Müller-Trutwin M
iScience; 2021 Oct; 24(10):103109. PubMed ID: 34622162
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.
Zuo W; Zhao X
Clin Immunol; 2021 Jun; 227():108727. PubMed ID: 33887436
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.
Macedo AB; Novis CL; Bosque A
Front Immunol; 2019; 10():2450. PubMed ID: 31681325
[TBL] [Abstract][Full Text] [Related]
13. The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.
Matz KM; Guzman RM; Goodman AG
Int Rev Cell Mol Biol; 2019; 345():35-136. PubMed ID: 30904196
[TBL] [Abstract][Full Text] [Related]
14. Adaptive NK cell responses in HIV/SIV infections: A roadmap to cell-based therapeutics?
Ram DR; Manickam C; Lucar O; Shah SV; Reeves RK
J Leukoc Biol; 2019 Jun; 105(6):1253-1259. PubMed ID: 30730588
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells in HIV-1 infection and therapy.
Mikulak J; Oriolo F; Zaghi E; Di Vito C; Mavilio D
AIDS; 2017 Nov; 31(17):2317-2330. PubMed ID: 28926399
[TBL] [Abstract][Full Text] [Related]
16. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
17. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
[TBL] [Abstract][Full Text] [Related]
18. Expression and activation of intracellular receptors TLR7, TLR8 and TLR9 in peripheral blood monocytes from HIV-infected patients.
Valencia Pacheco GJ; Pinzón Herrera F; Cruz López JJ; Vera Gamboa Ldel C; Pavía Ruiz N; Santos Rivero A; Sánchez Lugo S; Puerto F
Colomb Med (Cali); 2013 Apr; 44(2):92-9. PubMed ID: 24892454
[TBL] [Abstract][Full Text] [Related]
19. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.
Buitendijk M; Eszterhas SK; Howell AL
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):907-18. PubMed ID: 23316755
[TBL] [Abstract][Full Text] [Related]
20. Association of TLR7 variants with AIDS-like disease and AIDS vaccine efficacy in rhesus macaques.
Siddiqui RA; Krawczak M; Platzer M; Sauermann U
PLoS One; 2011; 6(10):e25474. PubMed ID: 22022401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
